BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7747795)

  • 1. Classical Noonan syndrome is not associated with deletions of 22q11.
    Robin NH; Sellinger B; McDonald-McGinn D; Zackai EH; Emanuel BS; Driscoll DA
    Am J Med Genet; 1995 Mar; 56(1):94-6. PubMed ID: 7747795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdeletion of 22q11 (CATCH 22) in children with conotruncal heart defect and extracardiac malformations.
    Alikaşifoğlu M; Malkoç N; Ceviz N; Ozme S; Uludoğan S; Tunçbilek E
    Turk J Pediatr; 2000; 42(3):215-8. PubMed ID: 11105620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2.
    Matsuoka R; Takao A; Kimura M; Imamura S; Kondo C; Joh-o K; Ikeda K; Nishibatake M; Ando M; Momma K
    Am J Med Genet; 1994 Nov; 53(3):285-9. PubMed ID: 7856665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
    Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
    Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.
    Lindsay EA; Goldberg R; Jurecic V; Morrow B; Carlson C; Kucherlapati RS; Shprintzen RJ; Baldini A
    Am J Med Genet; 1995 Jul; 57(3):514-22. PubMed ID: 7677167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region.
    Lindsay EA; Greenberg F; Shaffer LG; Shapira SK; Scambler PJ; Baldini A
    Am J Med Genet; 1995 Mar; 56(2):191-7. PubMed ID: 7625444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite DNA markers detects 95% of chromosome 22q11 deletions.
    Bonnet D; Cormier-Daire V; Kachaner J; Szezepanski I; Souillard P; Sidi D; Munnich A; Lyonnet S
    Am J Med Genet; 1997 Jan; 68(2):182-4. PubMed ID: 9028455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of 22q11 region deletions in patients with velopharyngeal insufficiency.
    Zori RT; Boyar FZ; Williams WN; Gray BA; Bent-Williams A; Stalker HJ; Rimer LA; Nackashi JA; Driscoll DJ; Rasmussen SA; Dixon-Wood V; Williams CA
    Am J Med Genet; 1998 Apr; 77(1):8-11. PubMed ID: 9557885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequency of 22q11 deletions in children with isolated conotruncal defects].
    Shen L; Xu YJ; Zhao PJ; Sun K
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):25-8. PubMed ID: 19149917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region.
    Nickel RE; Pillers DA; Merkens M; Magenis RE; Driscoll DA; Emanuel BS; Zonana J
    Am J Med Genet; 1994 Oct; 52(4):445-9. PubMed ID: 7747757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study.
    Takahashi K; Kido S; Hoshino K; Ogawa K; Ohashi H; Fukushima Y
    Eur J Pediatr; 1995 Nov; 154(11):878-81. PubMed ID: 8582397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions.
    Scirè G; Dallapiccola B; Iannetti P; Bonaiuto F; Galasso C; Mingarelli R; Boscherini B
    Am J Med Genet; 1994 Oct; 52(4):478-82. PubMed ID: 7747762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
    Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
    Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant "Opitz" GBBB syndrome due to a 22q11.2 deletion.
    McDonald-McGinn DM; Driscoll DA; Bason L; Christensen K; Lynch D; Sullivan K; Canning D; Zavod W; Quinn N; Rome J
    Am J Med Genet; 1995 Oct; 59(1):103-13. PubMed ID: 8849001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal atresia type III (glottic web) with 22q11.2 microdeletion: report of three patients.
    Fokstuen S; Bottani A; Medeiros PF; Antonarakis SE; Stoll C; Schinzel A
    Am J Med Genet; 1997 May; 70(2):130-3. PubMed ID: 9128930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural tube defects and deletions of 22q11.
    Nickel RE; Magenis RE
    Am J Med Genet; 1996 Dec; 66(1):25-7. PubMed ID: 8957506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
    Ravnan JB; Chen E; Golabi M; Lebo RV
    Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kabuki syndrome is not caused by a microdeletion in the DiGeorge/velocardiofacial chromosomal region within 22q 11.2.
    Li M; Zackai EH; Niikawa N; Kaplan P; Driscoll DA
    Am J Med Genet; 1996 Oct; 65(2):101-3. PubMed ID: 8911598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch.
    Rauch A; Hofbeck M; Leipold G; Klinge J; Trautmann U; Kirsch M; Singer H; Pfeiffer RA
    Am J Med Genet; 1998 Jul; 78(4):322-31. PubMed ID: 9714433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.